These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nanodrug-enhanced radiofrequency tumor ablation: effect of micellar or liposomal carrier on drug delivery and treatment efficacy. Moussa M; Goldberg SN; Kumar G; Sawant RR; Levchenko T; Torchilin VP; Ahmed M PLoS One; 2014; 9(8):e102727. PubMed ID: 25133740 [TBL] [Abstract][Full Text] [Related]
4. Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition. Ahmed M; Kumar G; Moussa M; Wang Y; Rozenblum N; Galun E; Goldberg SN Radiology; 2016 Apr; 279(1):103-17. PubMed ID: 26418615 [TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model. Yang W; Ahmed M; Tasawwar B; Levchenko T; Sawant RR; Collins M; Signoretti S; Torchilin V; Goldberg SN Int J Hyperthermia; 2011; 27(6):527-38. PubMed ID: 21846189 [TBL] [Abstract][Full Text] [Related]
6. Effect of thermal dose on heat shock protein expression after radio-frequency ablation with and without adjuvant nanoparticle chemotherapies. Moussa M; Goldberg SN; Kumar G; Levchenko T; Torchilin V; Ahmed M Int J Hyperthermia; 2016 Dec; 32(8):829-841. PubMed ID: 27600101 [TBL] [Abstract][Full Text] [Related]
7. Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells. Befani CD; Vlachostergios PJ; Hatzidaki E; Patrikidou A; Bonanou S; Simos G; Papandreou CN; Liakos P J Mol Med (Berl); 2012 Jan; 90(1):45-54. PubMed ID: 21909688 [TBL] [Abstract][Full Text] [Related]
8. RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model. Solazzo S; Mertyna P; Peddi H; Ahmed M; Horkan C; Goldberg SN Int J Hyperthermia; 2008 Nov; 24(7):560-7. PubMed ID: 18608584 [TBL] [Abstract][Full Text] [Related]
9. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Yang W; Ahmed M; Elian M; Hady el-SA; Levchenko TS; Sawant RR; Signoretti S; Collins M; Torchilin VP; Goldberg SN Radiology; 2010 Dec; 257(3):685-96. PubMed ID: 20858851 [TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation (RFA)-induced systemic tumor growth can be reduced by suppression of resultant heat shock proteins. Ahmed M; Kumar G; Gourevitch S; Levchenko T; Galun E; Torchilin V; Goldberg SN Int J Hyperthermia; 2018 Nov; 34(7):934-942. PubMed ID: 29631466 [TBL] [Abstract][Full Text] [Related]
11. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Ahmed M; Liu Z; Lukyanov AN; Signoretti S; Horkan C; Monsky WL; Torchilin VP; Goldberg SN Radiology; 2005 May; 235(2):469-77. PubMed ID: 15858089 [TBL] [Abstract][Full Text] [Related]
12. Combination radiofrequency (RF) ablation and IV liposomal heat shock protein suppression: reduced tumor growth and increased animal endpoint survival in a small animal tumor model. Yang W; Ahmed M; Tasawwar B; Levchenko T; Sawant RR; Torchilin V; Goldberg SN J Control Release; 2012 Jun; 160(2):239-44. PubMed ID: 22230341 [TBL] [Abstract][Full Text] [Related]
13. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Goldberg SN; Girnan GD; Lukyanov AN; Ahmed M; Monsky WL; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Torchillin VP; Halpern EF; Kruskal JB Radiology; 2002 Mar; 222(3):797-804. PubMed ID: 11867804 [TBL] [Abstract][Full Text] [Related]
15. Targeting STAT3 to Suppress Systemic Pro-Oncogenic Effects from Hepatic Radiofrequency Ablation. Kumar G; Goldberg SN; Gourevitch S; Levchenko T; Torchilin V; Galun E; Ahmed M Radiology; 2018 Feb; 286(2):524-536. PubMed ID: 28880787 [TBL] [Abstract][Full Text] [Related]
16. Hepatic radiofrequency ablation: markedly reduced systemic effects by modulating periablational inflammation via cyclooxygenase-2 inhibition. Kumar G; Goldberg SN; Wang Y; Velez E; Gourevitch S; Galun E; Ahmed M Eur Radiol; 2017 Mar; 27(3):1238-1247. PubMed ID: 27287478 [TBL] [Abstract][Full Text] [Related]
17. Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Monsky WL; Kruskal JB; Lukyanov AN; Girnun GD; Ahmed M; Gazelle GS; Huertas JC; Stuart KE; Torchilin VP; Goldberg SN Radiology; 2002 Sep; 224(3):823-9. PubMed ID: 12202721 [TBL] [Abstract][Full Text] [Related]
18. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation. Ahmed M; Monsky WE; Girnun G; Lukyanov A; D'Ippolito G; Kruskal JB; Stuart KE; Torchilin VP; Goldberg SN Cancer Res; 2003 Oct; 63(19):6327-33. PubMed ID: 14559820 [TBL] [Abstract][Full Text] [Related]
19. Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Solazzo SA; Ahmed M; Schor-Bardach R; Yang W; Girnun GD; Rahmanuddin S; Levchenko T; Signoretti S; Spitz DR; Torchilin V; Goldberg SN Radiology; 2010 Apr; 255(1):62-74. PubMed ID: 20160000 [TBL] [Abstract][Full Text] [Related]
20. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors. Birle DC; Hedley DW Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]